Damien Breheny

Damien Breheny is the Preclinical Assessment Manager in the Potentially Reduced Risk Substantiation department of British American Tobacco R&D. After qualifying with an MSc in Toxicology, he has worked in the field of in vitro alternatives for toxicological assessment for the past 20 years. He graduated with a PhD in genetic toxicology from the University of Wales, Swansea in 2010. Since beginning his career at BAT in 2002, he has specialised in the development and application of in vitro methods for toxicological assessment of cigarettes, and more recently e-cigarettes and tobacco heating products.